ArticleOncotarget2017

DCK expression, a potential predictive biomarker in the adjuvant gemcitabine chemotherapy for biliary tract cancer after surgical resection: results from a phase II study.

Sang Myung Woo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.